ADA preview: cardio data in diabetes, drug costs and healthcare reform
ADA, ADA 2017, American Diabetes Association, cardiology, Diabetes, Janssen, Novo Nordisk
0 Comment
Invokana data could suggest cardio benefit for SGLT2 class.